Supports translation of fundamental discoveries toward benefits to human health. Funds pre-clinical development and early clinical testing of novel regenerative medicine therapies.
DPFS is an ongoing scheme, with outline deadlines every 4 months.
Further details of open and future DPFS deadlines can be found on the submission deadlines page for the scheme.
The DPFS scheme is a key part of our Translational Research Strategy and supports the translation of fundamental discoveries toward benefits to human health. It funds the pre-clinical development and early clinical testing of novel therapeutics, devices and diagnostics, including “repurposing” of existing therapies.
Funded by the Industrial Strategy Challenge Fund, Health Data Research UK seeks proposals from NHS, academic and industry collaborations to inform the specification of the Digital Innovation Hub Programme – an interoperable infrastructure for research and innovation
You can apply to the Molecular & Cellular Medicine Board through four of our grant schemes.
You can apply to the Infections and Immunity Board through our four grant schemes.
The CRTF supports clinically active professionals within the UK to undertake a higher research degree. The scheme can also provide post-doctoral funding for applicants who achieved their PhD more than five years ago but who have not been research active since due to clinical training commitments.